<DOC>
	<DOCNO>NCT01362595</DOCNO>
	<brief_summary>This study determine safety possibility give amino acid , leucine , patient Diamond Blackfan anemia ( DBA ) dependent red blood cell transfusion . The leucine expect produce response patient DBA point red blood cell production increase . Red cell transfusion less frequent possibly discontinue . The investigator study side effect , , give leucine DBA patient . Leucine level leucine obtain baseline study . The drug leucine provide capsule form take 3 time day total 9 month .</brief_summary>
	<brief_title>Pilot Phase I/II Study Amino Acid Leucine Treatment Patients With Transfusion-Dependent Diamond Blackfan Anemia</brief_title>
	<detailed_description>Leucine provide participant form capsule take three time daily . Blood hemoglobin level monitor every 3-4 week 9 month . The entire study last 12-15 month length . Subjects must two year age old transfusion six month prior enrollment .</detailed_description>
	<mesh_term>Anemia</mesh_term>
	<mesh_term>Anemia , Diamond-Blackfan</mesh_term>
	<mesh_term>Red-Cell Aplasia , Pure</mesh_term>
	<mesh_term>Anemia , Aplastic</mesh_term>
	<mesh_term>Anemia , Hypoplastic , Congenital</mesh_term>
	<criteria>diagnose Diamond Blackfan anemia publish British Journal Hematology transfusion dependent age 2 year old adequate renal function adequate liver function negative BHCG patient menstruate female documentation adequate contraception sign informed consent Known hypersensitivity branch chain amino acid Diagnosis inborn error amino acid metabolism disorder Prior hematopoietic stem cell transplantation Pregnancy , plan become pregnant duration trial</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>leucine administration</keyword>
	<keyword>red blood cell transfusion</keyword>
	<keyword>Diamond Blackfan anemia</keyword>
</DOC>